GPT and metabolic dysfunction-associated steatotic liver disease: The resultant miRNA panel showed sensitivity and specificity superior to that of ALT and FIB-4 tests and had satisfactory diagnostic performance regardless of the NAFLD activity score (NAS) status (Tan et al., 2014).